NMA

(redirected from Non-Myeloablative)
AcronymDefinition
NMANational Motorists Association
NMANederlandse Mededingingsautoriteit
NMANational Medical Association
NMANational Mining Association
NMANew Model Army
NMANational Movie Awards
NMANepal Mountaineering Association (Kathmandu, Nepal)
NMANorth Mississippi Allstars
NMANational Meat Association
NMANigerian Medical Association (Abuja, Nigeria)
NMANational Management Association
NMANational Mapping Agencies
NMANormal Mode Analysis
NMANepal Medical Association
NMANevada Mining Association
NMANadic Methyl Anhydride
NMANorwegian Mapping Authority
NMANon-Medical Attendant
NMANobeyama Millimeter Array
NMANon-Myeloablative
NMANetwork Monitoring and Analysis (Bellcore)
NMANorthwest Motorcycle Association
NMANordic Marine Academy (Bergen, Norway)
NMANetWare Management Agent (Novell)
NMANational Micrographics Association (now part of AIIM)
NMANetwork Management and Administration (Bellcore)
NMANational Mustang Association
NMANumber of Methods Added
NMANormal Melting Agarose
NMANew Membership Application
NMANATO Military Authorities
NMANull Modem Adapter (Lucent)
NMANewfoundland Medical Association
NMANon-Medical Assessment
NMANo More Acronyms
NMANational Military Authority
NMANetwork Manifold Associates, Inc (California IT security)
NMANational Mine Academy
NMANational Management Award (insurance)
NMANational Maritime Alliance
NMANiagara Musky Association (est. 1994; fish population preservation)
NMANuclear Materials Accountability
NMANot My Aisle (flight attendant slang)
NMANon-Material Alternative
NMANon-Military Affiliated
NMANacionalin Mokjimo Agentra (Lithuanian: National Paying Agency; Vilnius, Lithuania)
NMANebraska Marksmanship Association (Papillion, NE)
NMANew Media Age (UK)
NMANorwegian Medicines Agency (regulatory authority)
NMANetwork Management Application (software)
References in periodicals archive ?
1) The next therapeutic choice was a non-myeloablative stem-cell transplant.
Gopal's ASH presentation is entitled Y-90 Ibritumomab Tiuxetan, Fludarabine, and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma.
The incidence of POF is lower in cases treated with non-myeloablative conditioning regimens and autologous transplantation (33).
For the first time, we were able to achieve engraftment, a state of mixed chimerism, and durable remissions in patients with refractory hematologic malignancies after a non-myeloablative transplant regimen," said Thomas Spitzer, MD, director of MGH's bone marrow transplant program, in a report published in the May 22nd issue of The Lancet.
We have previously reported the adverse prognostic value of PET+ in autologous transplants (AUTO) and disease refractoriness in pts undertaking a non-myeloablative allogeneic transplantation (NST).
Some progress has been demonstrated recently by using a less aggressive, non-myeloablative preparative regimen, followed by an infusion of unmanipulated bone marrow and the post-transplant use of a common chemotherapy drug, cyclophosphamide (Cy), but relapse is relatively common, especially in those with high-risk myeloid malignancies.
The demonstration of successful reversal of the disease using purified stem cells with non-myeloablative conditioning offers a novel strategy to treat autoimmune diseases such as lupus with decreased morbidity," said Ramkumar Mandalam, Ph.
Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) With or Without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non-Myeloablative Allogeneic HCT (auto-allo) for Patients With Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial [Abstract 41]
His current research interests include the investigation of non-myeloablative conditioning prior to allogeneic transplantation and the use of allogeneic and autologous hematopoietic transplantation for hematologic malignancies and selected solid tumors.
Rosenberg has identified and characterized a number of melanoma tumor-associated antigens, including gp100 and MART-1, and has developed a lymphodepleting non-myeloablative regimen used for adoptive cell therapy (ACT).
Matched Unrelated Donor (MUD) BMT Abstract #2515 -- Unrelated Donor Hematopoietic Stem Cell Transplantation after Administration of a Non-Myeloablative Conditioning Regimen of Fludarabine, Rabbit Anti-Thymocyte Globulin (rATG), and Total Body Irradiation (TBI).
Full browser ?